We focus on therapies for the treatment of bronchopulmonary disease
This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.
Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.
Vectura Group plc annual report for the year ended 31 March 2012
Vectura Group plc Preliminary Results for year ended 31st March 2012
JP Morgan HealthCare Conference
13 May 2013
Vectura establishes strategic partnership (Kinnovata) for new respiratory business in China
09 May 2013
Notice of Results
07 May 2013
Share price table
Full Year Results
Stay informed Register to our news alert and receive latest updates on news and events
For general enquiries, call us on +44 (0)1249 667700. For more specific enquiries, visit Contact us
Most computers will open PDF documents automatically, but you may need to download Adobe Reader.